Dr. Ashley Farrell Coughlin, MD

Dr. Coughlin practices at Valleywise Health Medical Center in Phoenix, Arizona, part of Valleywise Health.

Dr. Coughlin's NPI, 1528445871, was assigned on May 6, 2015. Dr. Coughlin graduated from St. George's University School of Medicine in 2015. Dr. Coughlin holds Connecticut license 060164.

Dr. Coughlin's primary practice is Valleywise Health Medical Center, at 2601 East Roosevelt Street, Phoenix, AZ 85008 in Maricopa County. The practice phone is (602) 344-5011.

Dr. Coughlin's primary practice is Valleywise Health Medical Center in Phoenix, Arizona, part of Valleywise Health. The medical group on file is District Medical Group. Dmand AI also links Dr. Coughlin to 9 more medical groups, 1 dialysis center and 1 group practice or clinic, each named with a free account. Dr. Coughlin's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Coughlin practices, 3 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Coughlin's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Coughlin is licensed in Connecticut.

CMS data shows 107 Medicare services from Dr. Coughlin across 2 procedure codes in 2024, all of them office visits, for 40 Medicare patients. Medicare paid $10,374 for them. Every service was in an office.

CMS counts 40 Medicare patients who saw Dr. Coughlin in 2024. The largest group is 75 to 84, with 14 patients. 75% of them have high cholesterol, and 75% have mood disorders. 35% are also on Medicaid. Their average risk score is 1.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Coughlin's median patient age at 42, with 46% women.

In 2024, Dr. Coughlin wrote 1,205 Medicare Part D claims for 156 patients. 94% of them were for generic drugs. CMS names the drug for 1,013 of them, across 31 drugs with 11 or more claims each, at $21,470 in total drug cost. In 2023, CMS named 99 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Coughlin for performance year 2024, reported through an alternative payment model (APM). Dr. Coughlin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 28 general payments to Dr. Coughlin from 13 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 94% of the total. ITI, Inc. paid the most, $220.

Dr. Coughlin graduated from St. George's University School of Medicine in 2015.